COPD 2.0: Bronchodilators, biologics and beyond - A systematic review.

Lung India · 2026 · PMC12857841 · PMID 41474430

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

1.24; RR 0.83; 95% CI, 0.70 to 0.98; P = 0.05) TERRANOVA: Similar trends observed, but results did not reach statistical significance.[ 8 ] Acute exacerbations treated with benralizumab trial The Acute exacerbations treated with benralizumab trial was a Phase 2, double-blind, double-dummy, active placebo-controlled randomized trial conducted in the UK.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.